IP Library Assignment 039312/0397
Patent Assignment
Reel/Frame 039312/0397

Security Agreement

Recorded: 2016-07-12 Pages: 10
Assignor
CELATOR PHARMACEUTICALS, INC.
Executed: 2016-07-12
Assignee
BANK OF AMERICA, N.A., AS COLLATERAL AGENT
BANK OF AMERICA PLAZA, 901 MAIN ST., MAIL CODE: TX1-492-14-06, DALLAS, TEXAS, 75202-3714
Covered Properties (19)
Liposome Loading with Metal Ions
Patent: 7,238,367 →
Application: 10/264,818 →
Publication: US 2003/0091621
Lipid Carrier Compositions with Enhanced Blood Stability
Patent: 8,518,437 →
Application: 10/294,474 →
Publication: US 2003/0124181
Compositions for Delivery of Drug Combinations
Patent: 9,271,931 →
Application: 10/553,373 →
Publication: US 2007/0298092
Fixed Ratio Drug Combination Treatments for Solid Tumors
Patent: 7,842,676 →
Application: 11/586,215 →
Publication: US 2009/0023680
Liposomal Formulations of Anthracycline Agents and Cytidine Analogs
Patent: 8,022,279 →
Application: 11/587,112 →
Publication: US 2007/0286897
Liposome Loading with Metal Ions
Patent: 7,744,921 →
Application: 11/842,130 →
Publication: US 2008/0044464
Spikeless Tie Plate Fasteners, Pre-Plated Railroad Ties and Related Assemblies and Methods
Patent: 7,850,090 →
Application: 12/004,891 →
Publication: US 2008/0121731
Fixed Drug Ratios for Treatment of Hematopoietic Cancers and Proliferative Disorders
Patent: 8,092,828 →
Application: 12/032,583 →
Publication: US 2008/0199515
Taxane Delivery System
Patent: 8,486,924 →
Application: 12/741,954 →
Publication: US 2010/0331290
Combination Methods and Compositions
Application: 13/122,454 →
Publication: US 2011/0223241
Liposomal Formulations of Anthracycline Agents and Cytidine Analogs
Patent: 8,431,806 →
Application: 13/237,807 →
Publication: US 2012/0009252
Particulate Constructs for Release of Active Agents
Application: 13/905,015 →
Publication: US 2013/0336915
Particulate Constructs for Release of Active Agents
Application: 13/969,449 →
Publication: US 2013/0337078
Method of Lyophilizing Liposomes
Application: 14/352,662 →
Publication: US 2014/0255475
Platinum Drug Formulations
Application: 14/931,679 →
Publication: US 2016/0058704
Compositions for Delivery of Drug Combinations
Application: 14/990,167 →
Publication: US 2016/0113871
Combinations of Taxanes and Molecularly Targeted Potentiating Agents
Application: 62/192,973 →
Combinations of Protein Kinase Inhibitors
Application: 62/252,396 →
Assays and Methods for Selecting a Treatment Regimen for a Subject with Leukemia
Application: 62/254,109 →
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest Jun 15, 2012
From: THOMAS, MCNERNEY & PARTNERS II, L.P.; TMP NOMINEE II, LLC; TMP ASSOCIATES II, L.P.; DOMAIN PARTNERS VI, L.P.
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 028385/0371 →
Assignment of Assignor's Interest Jul 23, 2013
From: MAYER, LAWRENCE D.; ALLEN, CHRISTINE J.
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 030858/0007 →
Assignment of Assignor's Interest Jul 23, 2013
From: PRUD'HOMME, ROBERT K.; SAAD, WALID S.
To: THE TRUSTEES OF PRINCETON UNIVERSITY
Reel/Frame 030858/0115 →
Assignment of Assignor's Interest Apr 10, 2014
From: PRUD'HOMME, ROBERT K.; SAAD, WALID S.
To: THE TRUSTEES OF PRINCETON UNIVERSITY
Reel/Frame 032651/0405 →
Assignment of Assignor's Interest Apr 10, 2014
From: MAYER, LAWRENCE D.; ALLEN, CHRISTINE J.
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 032651/0402 →
Assignment of Assignor's Interest Jun 2, 2014
From: CABRAL-LILLY, DONNA; MAYER, LAWRENCE; TARDI, PAUL; WATKINS, DAVID
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 033011/0685 →
Assignment of Assignor's Interest Sep 1, 2015
From: WAN, LEON; TARDI, PAUL; MAYER, LAWRENCE
To: CELATOR PHARMACEUTICALS INC.
Reel/Frame 036471/0633 →
Assignment of Assignor's Interest Nov 24, 2015
From: GORDON, MAX; TYNER, JEFFREY
To: OREGON HEALTH & SCIENCES UNIVERSITY
Reel/Frame 037134/0767 →
Assignment of Assignor's Interest Nov 24, 2015
From: TARDI, PAUL; MAYER, LAWRENCE
To: CELATOR PHARMACEUTICALS INC.
Reel/Frame 037134/0772 →
Assignment of Assignor's Interest Aug 2, 2016
From: TARDI, PAUL; JOHNSTONE, SHARON; MAYER, LAWRENCE
To: CELATOR PHARMACEUTICALS INC.
Reel/Frame 039315/0016 →
Assignment of Assignor's Interest Aug 3, 2016
From: TARDI, PAUL; HARASYM, TROY; WEBB, MURRAY; SHEW (DECEASED), CLIFFORD
To: CELATOR PHARMACEUTICALS INC.
Reel/Frame 039335/0418 →
Assignment of Assignor's Interest Aug 3, 2016
From: BCCA BRANCH
To: CELATOR PHARMACEUTICALS INC.
Reel/Frame 039335/0411 →
Assignment of Assignor's Interest Aug 3, 2016
From: MAYER, LAWRENCE; BALLY, MARCEL
To: BCCA BRANCH
Reel/Frame 039335/0404 →
Assignment of Assignor's Interest Mar 11, 2019
From: WAN, LEON; LUI, WINNIE; TARDI, PAUL; MAYER, LAWRENCE
To: CELATOR PHARMACEUTICALS INC.
Reel/Frame 048565/0361 →
Security Agreement May 5, 2021
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056151/0010 →
Release of Security Interest May 5, 2021
From: BANK OF AMERICA, N.A.
To: JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED
Reel/Frame 056150/0708 →
Corrective Assignment to Correct the Name of Assignee Oregon Health and Science University Previously Recorded at Reel: 037134 Frame: 0767. Assignor(S) Hereby Confirms the Assignment. Dec 2, 2022
From: GORDON, MAX; TYNER, JEFFREY
To: OREGON HEALTH & SCIENCE UNIVERSITY
Reel/Frame 062049/0370 →
Change of Name Aug 7, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 072341/0137 →
Corrective Assignment to Correct the Removal of 8 Property Numbers Previously Recorded at Reel: 072341 Frame: 0137. Assignor(S) Hereby Confirms the Change of Name. Oct 8, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073058/0985 →
Corrective Assignment to Correct the Remove 2 Application Numbers Previously Recorded at Reel: 07234 Frame: 0137. Assignor(S) Hereby Confirms the Change of Name. Oct 9, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073133/0142 →